113 related articles for article (PubMed ID: 16361866)
1. Expression of vascular adhesion protein-1 in atopic eczema.
Madej A; Reich A; Orda A; Szepietowski JC
Int Arch Allergy Immunol; 2006; 139(2):114-21. PubMed ID: 16361866
[TBL] [Abstract][Full Text] [Related]
2. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
3. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
4. Vascular adhesion protein-1 in human ischaemic stroke.
Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
[TBL] [Abstract][Full Text] [Related]
5. Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a).
Nemati H; Khodarahmi R; Rahmani A; Ebrahimi A; Amani M; Eftekhari K
Cell Biochem Funct; 2013 Jan; 31(1):36-40. PubMed ID: 22753196
[TBL] [Abstract][Full Text] [Related]
6. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
7. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.
Salmi M; Stolen C; Jousilahti P; Yegutkin GG; Tapanainen P; Janatuinen T; Knip M; Jalkanen S; Salomaa V
Am J Pathol; 2002 Dec; 161(6):2255-62. PubMed ID: 12466139
[TBL] [Abstract][Full Text] [Related]
8. Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report.
Asefi M; Vaisi-Raygani A; Khodarahmi R; Nemati H; Rahimi Z; Vaisi-Raygani H; Tavilani H; Pourmotabbed T
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1192-8. PubMed ID: 24118377
[TBL] [Abstract][Full Text] [Related]
9. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
Bournazou E; Samuels J; Zhou H; Krasnokutsky S; Patel J; Han T; Bencardino J; Rybak L; Abramson SB; Junker U; Brown KS; Attur M
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146362
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema.
Maintz L; Benfadal S; Allam JP; Hagemann T; Fimmers R; Novak N
J Allergy Clin Immunol; 2006 May; 117(5):1106-12. PubMed ID: 16675339
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
12. Different expression of adhesion molecules and tetraspanins of monocytes of patients with atopic eczema.
Jockers JJ; Novak N
Allergy; 2006 Dec; 61(12):1419-22. PubMed ID: 17073872
[TBL] [Abstract][Full Text] [Related]
13. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
14. [Concentration of sVAP in serum of patients with different forms of Lyme borreliosis].
Fota-Markowska H; Modrzewska R; Bielec D; Lis J; Przbyła A
Przegl Epidemiol; 2002; 56 Suppl 1():79-85. PubMed ID: 12194234
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease.
Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Shimizu K; Sato S
Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266
[TBL] [Abstract][Full Text] [Related]
16. Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis.
Kim HO; Cho SI; Chung BY; Ahn HK; Park CW; Lee CH
Clin Exp Dermatol; 2012 Jul; 37(5):521-6. PubMed ID: 22680616
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum and tissue levels of VAP-1 in colorectal cancer.
Ward ST; Weston CJ; Shepherd EL; Hejmadi R; Ismail T; Adams DH
BMC Cancer; 2016 Feb; 16():154. PubMed ID: 26912327
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
19. Vascular adhesion protein-1 and syndecan-1 in septic shock.
Sallisalmi M; Tenhunen J; Yang R; Oksala N; Pettilä V
Acta Anaesthesiol Scand; 2012 Mar; 56(3):316-22. PubMed ID: 22150439
[TBL] [Abstract][Full Text] [Related]
20. Soluble vascular adhesion protein-1: decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury.
Lin Z; Han M; Li H; Luo H; Zhang Y; Luo W
Clin Chim Acta; 2011 Aug; 412(17-18):1678-82. PubMed ID: 21645499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
